论文部分内容阅读
M——170是由上海医药工业研究院,实验室合成的一种对丝虫的成虫和幼虫均有杀灭作用的抗丝虫新药(片剂)。目前已在山东、浙江、广东、河南等省,分别以每公斤体重总量25、120、140毫克的剂量,分5—7天口服,进行部分微阳病人临床治疗,已取得较满意效果。根据部分临床应用疗效不低于海群生,服药后的副反应比海群生轻而少,这对今后消灭丝虫病又提供了一个良好的治疗药物。但在大面积防治上的应用还要作进一步的临床摸索。
M - 170 is a new antifibrillata (tablet) synthesized by Shanghai Institute of Pharmaceutical Industry, laboratory and has the killing effect on adults and larvae of filarial worms. Currently in Shandong, Zhejiang, Guangdong, Henan and other provinces, respectively, the total weight per kilogram of body weight 25,120,140 mg, 5-7 days orally, some patients with micro-positive clinical treatment, has achieved more satisfactory results. According to some of the clinical efficacy of not less than sea qun, after taking the side effects than the sea of light and less, which in the future to eliminate filariasis and provide a good therapeutic drug. However, the application of large-scale prevention and control should be further clinical exploration.